Analgesics: Comprehensive Study Notes on NSAIDs, Aspirin, Paracetamol, and Opioids

Fundamentals of Pain and Nociception

Pain is defined as a subjective, cognitive experience and sensation that is normally unpleasant and aversive. It serves a vital protective role by acting as a warning system to prevent damage to the body. Nociception, in contrast, refers to the objective measurement and physiological sensing of noxious stimuli through nerve endings that detect damaging or potentially damaging events. Pain is broadly categorized into acute and chronic forms. Acute pain is typically transient and results from immediate injury or conditions such as a stubbed toe, cut finger, headache, migraine, childbirth, myocardial infarction, toothache, appendicitis, or post-operative recovery. Chronic pain is often disabling and can persist long after initial tissue healing, potentially manifesting as hyperalgesia (increased sensitivity to pain) or allodynia (pain due to a stimulus that does not usually provoke pain). Examples of chronic pain include angina, arthritis, colitis, back pain, phantom limb pain, and diabetic neuropathy. Pain can also be classified as somatic, originating from the skin or joints and characterized by good discrimination, or visceral, originating from internal organs. Some pain may be referred, such as pain from coronary artery issues being felt in the arm.

Peripheral Nerve Endings and Nociceptor Classification

Nociceptors are specialized sensory endings located at peripheral nerve axons that sense damaging stimuli. These axons differ significantly in diameter and conduction speed. $A\alpha$ and $A\beta$ fibers are large-diameter (approx. $6-20\,\mu m$) myelinated fibers with high conduction speeds ($35-120\,\text{m/sec}$) primarily responsible for proprioception and light touch. Nociception is primarily handled by $A\delta$ and $C$ fibers. $A\delta$ fibers are lightly myelinated, medium-diameter ($1-5\,\mu m$) axons that conduct at speeds of $5-30\,\text{m/sec}$. They signal "fast" or sharp pain and respond to mechanical, thermal, and chemical stimuli. Examples include Type I $A\delta$ fibers with a thermal threshold of $\approx 53^{\circ}C$ and Type II with a threshold of $\approx 43^{\circ}C$. $C$ fibers are unmyelinated, small-diameter ($0.2-1.5\,\mu m$) axons with slow conduction speeds of <2\,\text{m/sec}. These fibers signal "slow," throbbing, or burning continuous pain associated with inflammation. Most $C$ fibers are polymodal, responding to noxious heat, mechanical, and chemical triggers such as capsaicin or bradykinin.

Chemical Mediators and Receptors in Nociception

Peripheral nociception involves various specialized receptors and chemical mediators. Some voltage-gated sodium channels, such as $Na_v1.8$ and $Na_v1.9$ (also known as SNS), are expressed almost exclusively in nociceptors. Bradykinin is a potent mediator formed from the proteolytic cleavage of circulating plasma proteins called kininogens during tissue injury and inflammation. It induces vasodilation, increases vascular permeability, and stimulates pain nerve endings, an effect that is significantly enhanced by prostaglandins. Capsaicin, the active component of chili peppers, selectively excites nociceptors by activating the transient receptor potential vanilloid receptor 1 (TRPV-1), which opens cation-permeable channels. These TRPV-1 receptors are also activated by noxious temperatures exceeding $45^{\circ}C$.

Prostaglandin Biosynthesis and COX Isoforms

Prostaglandins and thromboxanes (collectively known as prostanoids) are generated from phospholipids during inflammation and tissue damage. Phospholipids, the major constituents of cell membranes, are converted to arachidonic acid by the enzyme phospholipase $A_2$ (PLA2). PLA2 functions by removing the glycerol backbone from membrane phospholipids. Arachidonic acid is then converted into unstable endoperoxides (such as $PGG_2$ and $PGH_2$) by the enzyme cyclooxygenase (COX). There are two main isoforms of this enzyme: COX-1, which performs "housekeeping" roles in normal cell functions like gastric membrane protection and platelet aggregation; and COX-2, which is induced in inflammatory cells and produces the prostaglandins responsible for inflammation and fever. Prostaglandins themselves do not typically produce pain directly but rather sensitize and potentiate the effect of other mediators, like bradykinin, to noxious stimuli.

Specific Prostanoid Functions and Therapeutic Targets

Individual prostaglandins have diverse physiological roles. $PGD_2$ is involved in vasodilation, inhibiting platelet aggregation, and relaxing gastrointestinal (GI) smooth muscle. $PGI_2$ (prostacyclin) causes vasodilation, inhibits platelet aggregation, and regulates blood pressure through natriuresis (sodium excretion). $PGE_2$ is the major mediator of inflammation and fever, and depending on the receptor activated, it can contract or relax smooth muscle in the bronchi or GI tract and modulate gastric acid secretion. Most Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) act as competitive reversible inhibitors of both COX-1 and COX-2, preventing fatty acid substrates from reaching the catalytic domain by forming hydrogen bonds with the enzyme. Aspirin is unique as it causes irreversible inhibition by acetylating COX-1 at the Serine 530 residue within the hydrophobic channel.

Pharmacological Actions of NSAIDs and Paracetamol

NSAIDs exert three primary therapeutic effects: anti-inflammatory, analgesic, and antipyretic. The anti-inflammatory effect is mediated by reducing $PGE_2$ and $PGI_2$ levels, thereby decreasing vasodilation, edema, and swelling. Analgesically, NSAIDs are effective for mild to moderate pain (e.g., arthritis, vascular pain, toothache) by lowering prostaglandin levels that sensitize nociceptors to bradykinin. The antipyretic effect involves inhibiting prostaglandin production in the hypothalamus, which resets the temperature control set point disturbed during fever. Low-dose aspirin is also used as a cardiovascular treatment because it inhibits Thromboxane $A_2$ ($TXA_2$) in platelets. While it also inhibits $PGI_2$ in the vascular endothelium, the endothelium can synthesize more COX enzyme, whereas platelets cannot, shifting the balance toward platelet inhibition. Paracetamol, synthesized in the 1870s, has strong analgesic and antipyretic properties but weak anti-inflammatory effects. Its mechanism is distinct from aspirin, possibly involving the selective inhibition of a CNS-specific COX isoenzyme (COX-3).

Central Pain Processing and Gate Control Theory

Pain signals travel from the periphery to the CNS via ascending pathways, moving from the dorsal horn of the spinal cord to the thalamus and eventually the sensory cortex. The Gate Theory of pain, proposed by Wall and Melzack in 1965, suggests that the stimulus intensity of tissue damage is not always proportional to the perceived pain. A "gate" mechanism in the substantia gelatinosa of the dorsal horn can modulate pain signals before they reach the brain. This gate is controlled by inhibitory interneurons whose activity is influenced by both peripheral afferent input and descending inhibitory signals from higher brain centers, such as the periaqueductal gray (PAG) and the nucleus raphe magnus (NRM). These descending pathways utilize neurotransmitters like serotonin ($5-HT$), noradrenaline ($NA$), and enkephalins to modulate the sensation of pain.

Opioid Classification and Mechanisms of Action

Opioids are drugs that activate opioid receptors to treat acute and chronic pain, including cancer and neuropathic pain. The term "opiate" refers to natural products from opium (derived from the poppy $Papaver\,somniferum$), while "opioid" includes synthetic derivatives. Morphine analogues include heroin (diamorphine), which is highly lipid-soluble and crosses the blood-brain barrier rapidly, and codeine (methylmorphine), which is well-absorbed orally. Opioids act on three main types of G-protein coupled receptors: $\mu$, $\delta$, and $\kappa$. Activation of the $\mu$ receptor is responsible for most major effects, including analgesia, respiratory depression, euphoria, and physical dependence. At the cellular level, opioids inhibit adenylate cyclase (decreasing $cAMP$), activate $K^+$ channels (hyperpolarizing the cell), and decrease $Ca^{2+}$ influx, resulting in reduced neuronal excitability and inhibited neurotransmitter release (e.g., glutamate, substance P).

Clinical Pharmacology, Tolerance, and Dependence

Opioids produce several pharmacological actions beyond analgesia, such as sedation, cough suppression (antitussive), miosis (pinpoint pupils), nausea, and constipation. Tolerance develops within days due to adaptive upregulation of adenylate cyclase. Dependence can be physical, characterized by a withdrawal syndrome (shivering, runny nose) upon cessation, or psychological, involving intense drug craving. Withdrawal results in a "rebound" increase in $cAMP$ levels. Morphine undergoes significant first-pass metabolism and is converted to the active metabolite morphine-6-glucuronide, typically having a half-life of $3-6\,\text{hrs}$. Methadone has a much longer half-life (>24\,\text{hrs}) and is used to treat heroin addiction by managing physical cravings. Naloxone is a competitive antagonist used intravenously to reverse respiratory depression in opioid overdoses. Codeine is less potent, lacks euphoria, and is frequently combined with NSAIDs like ibuprofen for mild pain or used in cough syrups.